PUBLISHER: The Business Research Company | PRODUCT CODE: 1947096
PUBLISHER: The Business Research Company | PRODUCT CODE: 1947096
A sacral nerve stimulation device is a medical implant that uses electrical impulses to modulate nerves in the sacral area. It is used to treat conditions such as urinary incontinence and overactive bladder by regulating nerve activity, aiming to improve bladder function and enhance the quality of life for patients through targeted neurological intervention.
The main types of sacral nerve stimulation devices include electrical muscle stimulation devices and transcutaneous electrical nerve stimulation (TENS) devices. An electrical muscle stimulation device delivers electrical impulses to muscles via electrodes placed on the skin. Products in this category include external sacral nerve stimulation devices and implantable sacral nerve stimulation devices, which cater to different age groups such as pediatrics, adults, and geriatrics. These devices are used for various applications, including urinary incontinence, fecal incontinence, and other conditions, and are provided through hospitals, ambulatory surgical centers, and specialty clinics.
Tariffs are impacting the sacral nerve stimulation devices market by increasing costs of imported implantable electrodes, pulse generators, microelectronics, batteries, and programming units. Healthcare providers in North America and Europe are most affected due to reliance on specialized imported components, while Asia-Pacific faces cost pressure on device manufacturing and exports. These tariffs are increasing procedural costs and limiting access in some markets. However, they are also driving domestic production, regional component sourcing, and innovation in compact and cost-efficient neuromodulation systems.
The sacral nerve stimulation devices market research report is one of a series of new reports from The Business Research Company that provides sacral nerve stimulation devices market statistics, including sacral nerve stimulation devices industry global market size, regional shares, competitors with a sacral nerve stimulation devices market share, detailed sacral nerve stimulation devices market segments, market trends and opportunities, and any further data you may need to thrive in the sacral nerve stimulation devices industry. This sacral nerve stimulation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The sacral nerve stimulation devices market size has grown rapidly in recent years. It will grow from $1.48 billion in 2025 to $1.65 billion in 2026 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to growing prevalence of urinary incontinence, increasing geriatric population, advancements in neuromodulation technology, wider clinical acceptance of nerve stimulation therapies, expansion of urology specialty services.
The sacral nerve stimulation devices market size is expected to see rapid growth in the next few years. It will grow to $2.54 billion in 2030 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to increasing adoption of smart implantable devices, rising demand for long-term continence management, expansion of outpatient neuromodulation procedures, growing focus on personalized neurological therapies, increasing investments in bioelectronic medicine. Major trends in the forecast period include increasing adoption of implantable neuromodulation devices, rising demand for minimally invasive bladder control treatments, growing integration of programmable stimulation technologies, expansion of long-term neurological therapy solutions, enhanced focus on patient-specific therapy customization.
The growing prevalence of urological disorders is expected to boost the sacral nerve stimulation devices market. Urological disorders include various conditions affecting the urinary tract, kidneys, bladder, and prostate, ranging from acute to chronic. These disorders can be caused by multiple factors, including lifestyle issues such as poor diet, dehydration, and lack of exercise, which can contribute to kidney stones and other painful urinary tract conditions. Sacral nerve stimulation devices offer a minimally invasive treatment option for managing conditions such as urinary and fecal incontinence. For example, in April 2024, the National Institute of Diabetes and Digestive and Kidney Diseases reported that, on average, 651,446 individuals aged 65 and older are newly diagnosed with urinary incontinence annually. This growing prevalence of urological disorders is anticipated to drive the demand for sacral nerve stimulation devices.
Major companies in the Sacral Nerve Stimulation (SNS) devices market are focusing on developing advanced solutions, such as recharge-free sacral neuromodulation systems, to improve patient convenience and therapy adherence. Recharge-free sacral neuromodulation systems are implantable devices that stimulate the sacral nerves to treat bladder and bowel dysfunction without requiring regular battery recharging. For instance, in January 2025, Medtronic PLC, an Ireland-based medical technology company, received FDA approval in India for the InterStim X Sacral Neuromodulation (SNM) system to treat conditions such as overactive bladder (OAB), chronic fecal incontinence (FI), and non-obstructive urinary retention. The system features a proprietary fifth-generation battery delivering over 10 years of therapy without recharging, extendable up to 15 years on low-energy settings. It includes a smart programmer, similar to a smartphone, allowing patients to adjust up to 11 therapy settings discreetly at home or on the go. Additionally, it supports SureScan MRI technology, enabling safe full-body 1.5T and 3T MRI scans, with MRI mode controlled by patients under physician guidance.
In January 2024, Boston Scientific Corporation, a US-based biotechnology firm, acquired Axonics for $3.7 billion. This acquisition aims to expand Boston Scientific's medical technology portfolio by integrating Axonics' specialized devices for treating urinary and bowel dysfunction. Axonics Inc., based in the U.S., is known for its implantable sacral neuromodulation (SNM) systems designed to address urinary urge incontinence and urinary urgency frequency (UUF).
Major companies operating in the sacral nerve stimulation devices market are Abbott, Medtronic plc, Boston Scientific Corporation, Axonics Modulation Technologies, Laborie Medical Technologies, Beijing PINS Medical Co. Ltd., Neuspera Medical, Coloplast Group, Medtronic Neurovascular, NeuroPace Inc., Aleva Neurotherapeutics, LivaNova Neuromodulation, Nalu Medical, SetPoint Medical, NeuroSigma Inc., Saluda Medical, Soterix Medical, Inspire Medical Systems Inc., Synapse Biomedical Inc., Bioinduction Ltd
North America was the largest region in the sacral nerve stimulation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sacral nerve stimulation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the sacral nerve stimulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The sacral nerve stimulation devices market consists of sales of pulse generators, insulated wires, and electrode arrays. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Sacral Nerve Stimulation Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses sacral nerve stimulation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for sacral nerve stimulation devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sacral nerve stimulation devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.